Michael Fekete

Michael Fekete, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in SeaSpine Holdings Corp and Sagent Pharmaceuticals, Inc. Over a trading history stretching from 10 July 2014 to 5 January 2023, the count stands at 27 filings.

On the market, this insider has only ever bought: 4 purchases, €172k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 11 share grants and 9 option exercises.

In size, the median ticket on the buying side is €20k. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 9 January 2023: a transaction, in SeaSpine Holdings Corp. The latest purchase dates back some time: it was published 1,878 days ago, on 2 September 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.